Paper Details

  1. Home
  2. Paper Details

Managing tyrosine kinase inhibitors side effects in thyroid cancer.

Author: JarzabBarbara, KrajewskaJolanta, Paliczka-CieslikEwa

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Tyrosine kinase inhibitors (TKIs) are a new class of drugs effective against different growth factor receptors, inhibiting tumor cell growth and proliferation. Four TKIs are approved for RAI-refractory DTC or MTC: sorafenib, lenvatinib, vandetanib, and cabozantinib.
Paper Details　
Original Abstract of the Article :
Tyrosine kinase inhibitors (TKIs) are a new group of drugs that show the activity against receptors of different growth factors leading to the inhibition of tumor cells growth and proliferation. To date, four different TKIs have been approved for RAI-refractory DTC or MTC: sorafenib, lenvatinib, van...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/17446651.2017.1300526

データ提供：米国国立医学図書館（NLM）

Managing Tyrosine Kinase Inhibitor Side Effects in Thyroid Cancer: A Delicate Balance

Thyroid cancer can be a challenging adversary, but new medications called tyrosine kinase inhibitors (TKIs) are offering hope for patients. TKIs act like skilled archers, targeting specific growth factors that drive tumor growth. This study explores the use of TKIs for treating advanced thyroid cancer, focusing on the management of potential side effects, akin to a camel navigating a desert with both opportunities and risks.

The Promise and Challenges of TKIs in Thyroid Cancer

The study highlights the potential of TKIs for treating advanced thyroid cancer, but also recognizes the importance of managing potential side effects. It's like a camel seeking a lush oasis, aware that the journey might require navigating obstacles and adjusting its course along the way.

The Journey of Thyroid Cancer Treatment

This research underscores the need for a multi-faceted approach to thyroid cancer treatment, balancing the benefits of TKIs with the need for careful monitoring and management of potential side effects. Just like a camel navigating a desert, we need to be prepared for challenges and adjust our course accordingly, ultimately aiming for a successful outcome.

Dr. Camel's Conclusion

This study offers valuable insights into the evolving landscape of thyroid cancer treatment, highlighting both the promise and challenges of TKIs. It's a reminder that responsible use and careful monitoring are crucial for maximizing the benefits of these medications and ensuring the well-being of patients.

Date :
  1. Date Completed n.d.
  2. Date Revised 2019-11-20
Further Info :

Pubmed ID

30063430

DOI: Digital Object Identifier

10.1080/17446651.2017.1300526

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.